View Older Stories View More Recent Stories

Feb 25, 2021 07:00AM ESSA Pharma Announces Clinical Collaboration with Astellas to Evaluate the Combination of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
Feb 11, 2021 08:10AM ESSA Pharma Inc. (EPIX) Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
Feb 11, 2021 08:02AM ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
Feb 11, 2021 07:00AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020
Jan 13, 2021 07:14AM ESSA Pharma (EPIX) Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer
Jan 13, 2021 07:00AM ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer
Jan 12, 2021 06:45AM Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
Dec 15, 2020 05:01PM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020
Nov 25, 2020 07:00AM ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference
Nov 10, 2020 07:00AM ESSA Pharma to Participate in Upcoming Investor Conferences
Oct 26, 2020 05:01PM ESSA Pharma Inc. Announces Delisting from the TSX-V
Oct 24, 2020 07:18PM ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium
Oct 19, 2020 07:00AM ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia
Sep 21, 2020 07:00AM ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit
Sep 17, 2020 05:06PM ESSA Pharma Inc. (EPIX) Announces Presentation of Additional Preclinical Data for EPI-7386 at ESMO
Sep 17, 2020 05:05PM ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020
Sep 14, 2020 07:12AM ESSA Pharma Inc. (EPIX) Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Sep 14, 2020 07:00AM ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Sep 10, 2020 07:00AM ESSA Pharma to Participate in Multiple Upcoming Investor Conferences
Jul 15, 2020 07:02AM ESSA Pharma Inc. (EPIX) Reports First Patient Dosed in Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer
Jul 15, 2020 07:00AM ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer
Jun 22, 2020 07:32AM ESSA Pharma Inc. (EPIX) Highlights Therapeutic Potential of EPI-7386 at the 2020 American Association at AACR 2020 Virtual Meetings
Jun 22, 2020 07:30AM ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
May 27, 2020 07:00AM ESSA Pharma to Present at Jefferies Virtual Healthcare Conference
May 15, 2020 07:30AM ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting
May 7, 2020 05:05PM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020
Mar 31, 2020 07:05AM ESSA Pharma Inc. (EPIX) Reports Submission of IND for EPI-7386 for Prostate Cancer and Provides Business Update
Mar 31, 2020 07:00AM ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update
Feb 27, 2020 07:51PM ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders
Feb 13, 2020 05:48PM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019
Feb 10, 2020 06:15PM ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia
Dec 19, 2019 05:15PM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019
Oct 30, 2019 06:00AM ESSA Pharma Grants Stock Options
Oct 28, 2019 07:30AM ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oct 18, 2019 04:30PM ESSA Pharma Inc. (EPIX) Appoints Ari Brettman to Board Following Resignation of Otello Stampacchia from Board
Oct 18, 2019 04:15PM ESSA Announces Changes to its Board of Directors
Oct 7, 2019 02:04PM ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants
Sep 28, 2019 07:29AM ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress
Sep 19, 2019 07:30AM ESSA to Present at Ladenburg Thalmann Healthcare Conference
Sep 5, 2019 07:00AM ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
Aug 27, 2019 09:21AM ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million
Aug 23, 2019 10:47AM ESSA Pharma Inc. (EPIX) Anounces Proposed $36M Share Offering and Concurrent Private Placement
Aug 23, 2019 10:37AM ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
Aug 14, 2019 07:30AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019
Jul 31, 2019 04:45AM ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective
Jul 30, 2019 02:15AM ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics
Jul 15, 2019 07:30AM ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
Jul 8, 2019 03:43PM ESSA Pharma (EPIX) Provides Update on Court Hearing to Acquire Realm Therapeutics
Jul 8, 2019 03:39PM ESSA Provides Update on Court Hearing
Jun 26, 2019 06:08PM ESSA Provides an Update to the Acquisition of Realm Therapeutics
View More Recent Stories View Older Stories